Effect of allulose administration on glucose metabolism: a systematic review and meta-analysis of randomized controlled trials
Gaceta Médica de México · 11.11.2026 · 162 (3)
DOI: 10.24875/gmm.25000234 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Gaceta Médica de México, online erschienen am 11.11.2026. Verfasst von Maryam Emadzadeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Development Unit, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Blood Glucose.
Abstract (Originalsprache)
BACKGROUND: Some studies have reported that allulose consumption improves postprandial glucose and insulin levels, while others indicate minimal or no effects. Therefore, we assessed the impact of allulose administration on glycemic parameters through a meta-analysis of randomized controlled trials (RCTs). MATERIAL AND METHODS: The search was made in PubMed, Web of Science, Scopus, ClinicalTrials.gov, Cochrane Library, and Google Scholar databases. RCTs with either parallel or cross-over design, investigating the effects of allulose on glycemic parameters, and exhibiting complete outcomes at baseline and the end of follow-up in both intervention and control groups were eligible for meta-analysis. Nevertheless, uncontrolled trials, non-randomized trials, trials without a control group, observational studies, and incomplete outcomes at baseline or the end of the follow-up were exclusion criteria. Meta-analysis was performed using comprehensive meta-analysis V2 software. RESULTS: The meta-analysis of 12 clinical trials showed that allulose significantly decreased plasma glucose in the subgroup with high glycemic index control groups (mean difference [MD] = -4.23 mg/dL (95% confidence interval [CI]: -7.11, -1.35), p = 0.004), but no significant effect in the low glycemic index control groups (MD = 0.68 mg/dL (95% CI: -1.84, 3.21), p = 0.59). Allulose did not affect insulin levels in studies with either a high (MD = -1.52 μU/mL (95% CI: -4.18, 1.13), p = 0.26) and low (MD = -0.19 μU/mL (95% CI: -1.33, 0.95), p = 0.74) glycemic index control group. Finally, allulose significantly reduced the area under the curve of plasma glucose in both subgroups with high (MD = -2.34 (95% CI: -2.94, -1.74), p < 0.001) and low (MD = -0.56 (95% CI: -0.99, -0.14), p = 0.009) glycemic index control intervention, but this variable was not changed for insulin in studies with high (MD = -0.37 (95% CI: -1.01, 0.26), p = 0.25) and low (MD = -0.21 (95% CI: -0.45, 0.03), p = 0.08) glycemic index control group. CONCLUSION: We suggest that the administration of allulose reduces plasma glucose but does not affect insulin levels. INTRODUCCIÓU: Algunos estudios han reportado que el consumo de alulosa mejora los niveles de glucosa e insulina posprandiales, mientras que otros indican efectos mínimos o nulos. Evaluamos el impacto de la administración de alulosa en los parámetros glucémicos a través de un meta-análisis de ensayos controlados aleatorizados. MATERIAL Y MÉtodos: La búsqueda fue realizada en las bases de datos PubMed, Web of Science, Scopus, ClinicalTrials.gov, Cochrane Library y Google Académico. Los ensayos controlados aleatorizados con diseño paralelo o cruzado que investigaron los efectos de la alulosa sobre los parámetros glucémicos y mostraron resultados completos al inicio y al final del seguimiento, tanto en el grupo de intervención como en el grupo control, fueron elegibles para el meta-análisis. Sin embargo, los estudios no controlados, no aleatorizados, sin grupo control, los estudios observacionales y los resultados incompletos al inicio o al final del seguimiento fueron criterios de exclusión. El meta-análisis se realizó utilizando el software Comprehensive Meta-Analysis V2. RESULTADOS: El meta-análisis de 12 ensayos clínicos mostró que la alulosa redujo significativamente la glucosa plasmática en el subgrupo control con índice glucémico alto (diferencia de medias [DM] = -4.23 mg/dL (IC95%:-7.11, -1.35), p = 0.004), pero no mostró un efecto significativo en los grupos control con índice glucémico bajo (DM = 0.68mg/dL (95% CI: -1.84, 3.21), p = 0.59). La alulosa no afectó los niveles de insulina en estudios con grupos control con índice glucémico alto (DM = -1.52 μU/mL (95% CI: -4.18, 1.13), p = 0.26) y bajo (DM = -0.19 μU/mL (95% CI: -1.33, 0.95), p = 0.74). Finalmente, la alulosa redujo significativamente el área bajo la curva de glucosa plasmática en ambos subgrupos con intervención de control con índice glucémico alto (DM = -2.34 (95% CI: -2.94, -1.74), p < 0.001) y bajo (DM = -0.56 (95% CI: -0.99, -0.14), p = 0.009), pero esta variable no se modificó para la insulina en estudios con índice glucémico alto (DM = -0.37 (95% CI: -1.01, 0.26), p = 0.25) y bajo (MD = -0.21 (95% CI: -0.45, 0.03), p = 0.08). CONCLUSIONES: La administración de alulosa reduce la glucosa plasmática pero no afecta los niveles de insulina.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Development Unit, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
- Metabolic Syndrome Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Applied Biomedical Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Hull York Medical School, University of Hull, Hull, United Kingdom.
Zitieren
APA
Emadzadeh, M., Sahebkar, A., Abdalla, M. A., Karav, S., Jamialahmadi, T., & Simental-Mendía, L. E. (2026). Effect of allulose administration on glucose metabolism: a systematic review and meta-analysis of randomized controlled trials. Gaceta Médica de México, 162(3). https://doi.org/10.24875/gmm.25000234
Vancouver
Emadzadeh M, Sahebkar A, Abdalla MA, Karav S, Jamialahmadi T, Simental-Mendía LE. Effect of allulose administration on glucose metabolism: a systematic review and meta-analysis of randomized controlled trials. Gaceta Médica de México. 2026;162(3). doi:10.24875/gmm.25000234
BibTeX
@article{Emadzadeh2026,
author = {Emadzadeh, Maryam and Sahebkar, Amirhossein and Abdalla, Mohammed A and Karav, Sercan and Jamialahmadi, Tannaz and Simental-Mendía, Luis E},
title = {Effect of allulose administration on glucose metabolism: a systematic review and meta-analysis of randomized controlled trials},
journal = {Gaceta Médica de México},
year = {2026},
volume = {162},
number = {3},
doi = {10.24875/gmm.25000234}
}
EUVIMED